Showing results (771-780 of 893) with videos related to
Sort By:
Pageof 90
American Heart Journal|December 17, 2013
Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillationMichiel Rienstra, Xiaoyan Yin, Martin G Larson, et al.Journal of Cardiac Failure|June 24, 2021
The Impact of Depression on Outcomes in Patients With Heart Failure and Reduced Ejection Fraction Treated in the GUIDE-IT TrialFouad Chouairi, Michael A Fuery, Clancy W Mullan, et al.Journal of the American College of Cardiology|November 24, 2018
Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart FailureDaniel B Mark, Patricia A Cowper, Kevin J Anstrom, et al.Circulation|November 15, 2021
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved TrialJaved Butler, Gerasimos Filippatos, Tariq Jamal Siddiqi, et al.Journal of Hematology & Oncology|January 7, 2022
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committeeJames L Januzzi, Joseph M Garasic, Scott E Kasner, et al.European Journal of Heart Failure|October 1, 2015
Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohortAntonio Teixeira, Jiri Parenica, Jin Joo Park, et al.The American Journal of Cardiology|September 28, 2011
Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD])Toru Suzuki, Eric M Isselbacher, Christoph A Nienaber, et al.European Heart Journal|October 21, 2025
Efficacy of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms: results from the SEQUOIA-HCM trialMartin S Maron, Juan Ramon Gimeno, Josef Veselka, et al.European Journal of Heart Failure|August 30, 2017
Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched studyEtienne Gayat, Mattia Arrigo, Simona Littnerova, et al.European Heart Journal|January 9, 2021
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trialJaved Butler, Stefan D Anker, Gerasimos Filippatos, et al.Pageof 90